Eupraxia Pharmaceuticals's total assets for Q1 2025 were C$29.23M, a decrease of -16.34% from the previous quarter. TSE:EPRX total liabilities were C$2.20M for the fiscal quarter, a -29.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.